Targeting HER2 in Biliary Tract Carcinomas: Challenges and Opportunities
Oncol Res Treat
.
2021;44(1-2):1-3.
doi: 10.1159/000513847.
Epub 2021 Jan 13.
Authors
Dieter Koeberle
1
,
Ralph Fritsch
2
Affiliations
1
Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland, dieter.koeberle@claraspital.ch.
2
Department of Medical Oncology and Hematology, Claraspital Basel and University of Bern, Bern, Switzerland.
PMID:
33440395
DOI:
10.1159/000513847
No abstract available
Publication types
Editorial
MeSH terms
Biliary Tract Neoplasms* / drug therapy
Biliary Tract*
Carcinoma*
Humans
Receptor, ErbB-2
Substances
Receptor, ErbB-2